Central Nervous System Embryonal Tumor

Observed

→ investigated in trials for

Cyclophosphamidesmall molecule

24 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Etoposidesmall molecule

17 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vincristinesmall molecule

17 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall molecule

15 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carboplatinsmall molecule

13 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Filgrastimother

10 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall molecule

10 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Topotecansmall molecule

8 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lomustinesmall molecule

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Methotrexatesmall molecule

6 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sonidegibsmall molecule

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thiotepasmall molecule

6 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Melphalansmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Central Nervous System Embryonal Tumor studied in …STUDIED_INderived10 of 240show all (up to 200)
→ studied in	NCT01445288completed Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped CURATED_BROADER · 240 trials mapped (85 active)	—	—	Medulloblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07346157Phase 1/Phase 2 · recruiting Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease · condition mapped CURATED_BROADER · 240 trials mapped (85 active)	—	—	Medulloblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02040376Phase 3 · completed Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma · condition mapped ALIAS · 240 trials mapped (85 active)	—	—	Medulloblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04868799completed Finding New Targets by Proteomic Approaches (InnovRT1) · condition mapped ALIAS · 240 trials mapped (85 active)	—	—	Atypical Teratoid/Rhabdoid Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT05230758Phase 3 · recruiting Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour · condition mapped ONTOLOGY_EXACT · 240 trials mapped (85 active)	—	—	Childhood Medulloblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07830134NA · recruiting Cognitive Rehabilitation for Survivors of Childhood Medulloblastoma Using Real Time Hemodynamic Neurofeedback · condition mapped ONTOLOGY_EXACT · 240 trials mapped (85 active)	—	—	Childhood Medulloblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 240 trials mapped (85 active)	—	—	Childhood Medulloblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03251989completed Rare CNS Tumors Outcomes &Risk · condition mapped CURATED_BROADER · 240 trials mapped (85 active)	—	—	Medulloblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 240 trials mapped (85 active)	—	—	Medulloblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06804655Phase 2 · recruiting Pharmacoscopy for Patients With Refractory Primary Brain Tumors · condition mapped CURATED_BROADER · 240 trials mapped (85 active)	—	—	Medulloblastoma	1	Observed	clinicaltrials	graph →

Central Nervous System Embryonal Tumor studied in …STUDIED_INderived10 of 240show all (up to 200)

→ studied in

NCT01445288completed

Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped CURATED_BROADER · 240 trials mapped (85 active)

—

Observed

→ studied in

NCT07346157Phase 1/Phase 2 · recruiting

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease · condition mapped CURATED_BROADER · 240 trials mapped (85 active)

—

Observed

→ studied in

NCT02040376Phase 3 · completed

Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma · condition mapped ALIAS · 240 trials mapped (85 active)

—

Observed

Atypical Teratoid/Rhabdoid Tumor

→ studied in

NCT04868799completed

Finding New Targets by Proteomic Approaches (InnovRT1) · condition mapped ALIAS · 240 trials mapped (85 active)

—

Observed

Childhood Medulloblastoma

→ studied in

NCT05230758Phase 3 · recruiting

Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour · condition mapped ONTOLOGY_EXACT · 240 trials mapped (85 active)

—

Observed

Childhood Medulloblastoma

→ studied in

NCT07830134NA · recruiting

Cognitive Rehabilitation for Survivors of Childhood Medulloblastoma Using Real Time Hemodynamic Neurofeedback · condition mapped ONTOLOGY_EXACT · 240 trials mapped (85 active)

—

Observed

Childhood Medulloblastoma

→ studied in

NCT03210714Phase 2 · active not recruiting

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 240 trials mapped (85 active)

—

Observed

→ studied in

NCT03251989completed

Rare CNS Tumors Outcomes &Risk · condition mapped CURATED_BROADER · 240 trials mapped (85 active)

—

Observed

→ studied in

NCT03698994Phase 2 · active not recruiting

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 240 trials mapped (85 active)

—

Observed

→ studied in

NCT06804655Phase 2 · recruiting

Pharmacoscopy for Patients With Refractory Primary Brain Tumors · condition mapped CURATED_BROADER · 240 trials mapped (85 active)

—

Observed